AI-quantified CCTA reveals subclinical atherosclerosis invisible to CAC 0 scoring and enables plaque-directed therapy monitoring in individual patients.
Share your take
Add a clinician perspective alongside expert commentary.
Ronald P. Karlsberg (Mon,) studied this question.